Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Fedor V Moiseyenko

8PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Aug 28, 2025
Interconnection of Gut Microbiome and Efficacy of Immune Checkpoint Inhibitors in Inoperable Non-Small-Cell Lung Cancer.

Fedor Moiseenko, Andrey Kechin, Maksim Koryukov

|Jun 13, 2025
Baseline Radiomics as a Prognostic Tool for Clinical Benefit from Immune Checkpoint Inhibition in Inoperable NSCLC Without Activating Mutations.

Fedor Moiseenko, Marko Radulovic, Nadezhda Tsvetkova

|Sep 04, 2024
Epidermal growth factor receptor-mutated lung carcinomas with insufficient response to epidermal growth factor receptor inhibitors.

Fedor Moiseenko, Ekaterina Kuligina, Ekaterina Elsakova

|Jun 06, 2024
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous <i>EGFR</i>-Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY Trial.

D Ross Camidge, Jair Bar, Hidehito Horinouchi

|Feb 11, 2023
Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in <i>BRCA1</i>-Driven Breast Cancer Patients.

Anna P Sokolenko, Fedor V Moiseyenko, Aglaya G Iyevleva

|Oct 21, 2022
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance.

Fedor Moiseenko, Alexey Bogdanov, Vitaliy Egorenkov

Pageof 2

Frequent Collaborators

3 joint publications

Evgeny N Imyanitov

3 joint publications

Ekaterina S Kuligina

2 joint publications

Albina S Zhabina

2 joint publications

Nikita Volkov

2 joint publications

Ekaterina Elsakova

1 joint publications

Jair Bar

1 joint publications

Hidehito Horinouchi

1 joint publications

Irfan Cicin

1 joint publications

Alona Zer

1 joint publications

Kristof Cuppens

Frequent Collaborators

3 joint publications

Evgeny N Imyanitov

3 joint publications

Ekaterina S Kuligina

2 joint publications

Albina S Zhabina

2 joint publications

Nikita Volkov

Top Related Videos

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
08:42

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)

Published on : Jun 27, 2025

540
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on : Feb 25, 2020

6.9K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

8.8K
See more related videos

Top Related Videos

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
08:42

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)

Published on : Jun 27, 2025

540
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on : Feb 25, 2020

6.9K
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

8.8K
See more related videos